Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shiwei Anshen Granules for Chronic Insomnia
NCT07895329Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Nov 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial of Shiwei Anshen granules in Insomnia (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Pittsburgh Sleep Quality Index at 8 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
Shiwei Anshen granules
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07895329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895329.